| Year |
Citation |
Score |
| 2023 |
Bi X, Xie S, Wu S, Cao W, Lin Y, Yang L, Jiang T, Deng W, Wang S, Liu R, Gao Y, Shen G, Chang M, Hao H, Xu M, et al. Changes of natural killer cells' phenotype in patients with chronic hepatitis B in intermittent interferon therapy. Frontiers in Immunology. 14: 1116689. PMID 36793722 DOI: 10.3389/fimmu.2023.1116689 |
0.335 |
|
| 2023 |
Zhang L, Bi X, Chen X, Zhang L, Xiong Q, Cao W, Lin Y, Yang L, Jiang T, Deng W, Wang S, Wu S, Liu R, Gao Y, Shen G, et al. A nomogram based on HBeAg, AST, and age to predict non-minimal liver inflammation in CHB patients with ALT <80 U/L. Frontiers in Immunology. 13: 1119124. PMID 36741383 DOI: 10.3389/fimmu.2022.1119124 |
0.343 |
|
| 2023 |
Zeng Z, Liu R, Cao W, Yang L, Lin Y, Bi X, Jiang T, Deng W, Wang S, Lu H, Sun F, Shen G, Chang M, Lu Y, Wu S, et al. Study on pathological and clinical characteristics of chronic HBV infected patients with HBsAg positive, HBV DNA negative, HBeAg negative. Frontiers in Immunology. 13: 1113070. PMID 36685494 DOI: 10.3389/fimmu.2022.1113070 |
0.339 |
|
| 2022 |
Sun F, Li Z, Hu L, Deng W, Jiang T, Wang S, Bi X, Lu H, Yang L, Lin Y, Zeng Z, Shen G, Liu R, Chang M, Wu S, et al. Sustained viral response and relapse after discontinuation of oral antiviral drugs in HBeAg-positive patients with chronic hepatitis B infection. Frontiers in Immunology. 13: 1082091. PMID 36505492 DOI: 10.3389/fimmu.2022.1082091 |
0.349 |
|
| 2022 |
Zeng Z, Hao H, Bi X, Lin Y, Yang L, Wang S, Shen G, Chang M, Jiang T, Deng W, Lu H, Sun F, Lu Y, Gao Y, Liu R, et al. Study on liver histopathology of chronic HBV infected patients with different normal ALT values. Frontiers in Immunology. 13: 1069752. PMID 36483546 DOI: 10.3389/fimmu.2022.1069752 |
0.329 |
|
| 2022 |
Cao W, Lu H, Zhang L, Wang S, Deng W, Jiang T, Lin Y, Yang L, Bi X, Lu Y, Zhang L, Shen G, Liu R, Chang M, Wu S, et al. Functional molecular expression of nature killer cells correlated to HBsAg clearance in HBeAg-positive chronic hepatitis B patients during PEG-IFN α-2a therapy. Frontiers in Immunology. 13: 1067362. PMID 36479104 DOI: 10.3389/fimmu.2022.1067362 |
0.33 |
|
| 2022 |
Wang F, Song M, Hu Y, Yang L, Bi X, Lin Y, Jiang T, Deng W, Wang S, Sun F, Zeng Z, Lu Y, Shen G, Liu R, Chang M, et al. The relation of the frequency and functional molecules expression on plasmacytoid dendritic cells to postpartum hepatitis in women with HBeAg-positive chronic hepatitis B virus infection. Frontiers in Immunology. 13: 1062123. PMID 36439153 DOI: 10.3389/fimmu.2022.1062123 |
0.307 |
|
| 2022 |
Xie S, Yang L, Bi X, Deng W, Jiang T, Lin Y, Wang S, Zhang L, Liu R, Chang M, Wu S, Gao Y, Hao H, Shen G, Xu M, et al. Cytokine profiles and CD8+ T cells in the occurrence of acute and chronic hepatitis B. Frontiers in Immunology. 13: 1036612. PMID 36353632 DOI: 10.3389/fimmu.2022.1036612 |
0.317 |
|
| 2022 |
Li M, Gao Y, Yang L, Lin Y, Deng W, Jiang T, Bi X, Lu Y, Zhang L, Shen G, Liu R, Wu S, Chang M, Xu M, Hu L, et al. Dynamic changes of cytokine profiles and virological markers during 48 weeks of entecavir treatment for HBeAg-positive chronic hepatitis B. Frontiers in Immunology. 13: 1024333. PMID 36203581 DOI: 10.3389/fimmu.2022.1024333 |
0.365 |
|
| 2022 |
Cao W, Xie S, Zhang L, Bi X, Lin Y, Yang L, Lu Y, Liu R, Chang M, Wu S, Shen G, Dong J, Xie Y, Li M. Expression of Functional Molecule on Plasmacytoid Dendritic Cells Is Associated With HBsAg Loss in HBeAg-Positive Patients During PEG-IFN α-2a Treatment. Frontiers in Immunology. 13: 891424. PMID 35663955 DOI: 10.3389/fimmu.2022.891424 |
0.301 |
|
| 2022 |
Wu S, Yi W, Gao Y, Deng W, Bi X, Lin Y, Yang L, Lu Y, Liu R, Chang M, Shen G, Hu L, Zhang L, Li M, Xie Y. Immune Mechanisms Underlying Hepatitis B Surface Antigen Seroclearance in Chronic Hepatitis B Patients With Viral Coinfection. Frontiers in Immunology. 13: 893512. PMID 35634301 DOI: 10.3389/fimmu.2022.893512 |
0.372 |
|
| 2022 |
Li M, Zhang L, Xie S, Sun F, Zeng Z, Deng W, Jiang T, Bi X, Lin Y, Yang L, Lu Y, Shen G, Liu R, Wu S, Chang M, et al. Dynamic Changes of Cytokine Profiles and Virological Markers Associated With HBsAg Loss During Peginterferon Alpha-2a Treatment in HBeAg-Positive Chronic Hepatitis B Patients. Frontiers in Immunology. 13: 892031. PMID 35603222 DOI: 10.3389/fimmu.2022.892031 |
0.341 |
|
| 2021 |
Cao W, Li M, Zhang L, Lu Y, Wu S, Shen G, Chang M, Liu R, Gao Y, Hao H, Hu L, Yi W, Pan CQ, Xie Y. The Characteristics of Natural Killer Cells in Chronic Hepatitis B Patients Who Received PEGylated-Interferon versus Entecavir Therapy. Biomed Research International. 2021: 2178143. PMID 33575322 DOI: 10.1155/2021/2178143 |
0.385 |
|
| 2021 |
Pan CQ, Li MH, Yi W, Zhang L, Lu Y, Hao HX, Wan G, Cao WH, Wang XY, Ran CP, Shen G, Wu SL, Chang M, Gao YJ, Xie Y. Outcome of Chinese Patients with Hepatitis B at 96 Weeks after Functional Cure With IFN versus Combination Regimens. Liver International : Official Journal of the International Association For the Study of the Liver. PMID 33486874 DOI: 10.1111/liv.14801 |
0.382 |
|
| 2020 |
Liu R, Chen Y, Guo J, Li M, Lu Y, Zhang L, Shen G, Wu S, Chang M, Hu L, Hao H, Zhang H, Xie Y. The reduction in CD8PD-1 T cells in liver histological tissue is related to Pegylated IFN-α therapy outcomes in chronic hepatitis B patients. Bmc Infectious Diseases. 20: 590. PMID 32778058 DOI: 10.1186/s12879-020-05320-z |
0.314 |
|
| 2019 |
Xie Y, Yi W, Zhang L, Lu Y, Hao HX, Gao YJ, Ran CP, Lu HH, Chen QQ, Shen G, Wu SL, Chang M, Ping-Hu L, Liu RY, Sun L, et al. Evaluation of a logistic regression model for predicting liver necroinflammation in hepatitis B e antigen-negative chronic hepatitis B patients with normal and minimally increased alanine aminotransferase levels. Journal of Viral Hepatitis. 26: 42-49. PMID 31380591 DOI: 10.1111/jvh.13163 |
0.314 |
|
| 2019 |
Li MH, Yi W, Zhang L, Lu Y, Lu HH, Shen G, Wu SL, Hao HX, Gao YJ, Chang M, Liu RY, Hu LP, Cao WH, Chen QQ, Li JN, et al. Predictors of sustained functional cure in hepatitis B envelope antigen-negative patients achieving hepatitis B surface antigen seroclearance with interferon-alpha-based therapy. Journal of Viral Hepatitis. 26: 32-41. PMID 31380582 DOI: 10.1111/jvh.13151 |
0.354 |
|
| 2019 |
Liu R, Guo J, Lu Y, Zhang L, Shen G, Wu S, Chang M, Hu L, Hao H, Li M, Xie Y. Changes in APRI and FIB-4 in HBeAg-negative treatment-naive chronic hepatitis B patients with significant liver histological lesions receiving 5-year entecavir therapy. Clinical and Experimental Medicine. PMID 31111345 DOI: 10.1007/s10238-019-00560-z |
0.307 |
|
| 2018 |
Li MH, Lu Y, Zhang L, Wang XY, Ran CP, Hao HX, Zhang D, Qu XJ, Shen G, Wu SL, Cao WH, Qi TL, Liu RY, Hu LP, Chang M, et al. Association of Cytokines with Alanine Aminotransferase, Hepatitis B Virus Surface Antigen and Hepatitis B Envelope Antigen Levels in Chronic Hepatitis B. Chinese Medical Journal. 131: 1813-1818. PMID 30058578 DOI: 10.4103/0366-6999.237394 |
0.326 |
|
| 2017 |
Zhang L, Li MH, Cao WH, Qi TL, Lu Y, Wu SL, Hao HX, Shen G, Liu RY, Hu LP, Chang M, Hua WH, Song SJ, Wan G, Xie Y. Negative Correlation of Serum Hepatitis B Surface Antigen and Hepatitis B e Antigen Levels with the Severity of Liver Inflammation in Treatment-naïve Patients with Chronic Hepatitis B Virus Infection. Chinese Medical Journal. 130: 2697-2702. PMID 29133758 DOI: 10.4103/0366-6999.218000 |
0.376 |
|
| 2017 |
Li MH, Zhang D, Zhang L, Qu XJ, Lu Y, Shen G, Wu SL, Chang M, Liu RY, Hu LP, Hao HX, Hua WH, Song SJ, Wan G, Liu SA, et al. Ratios of T-helper 2 Cells to T-helper 1 Cells and Cytokine Levels in Patients with Hepatitis B. Chinese Medical Journal. 130: 1810-1815. PMID 28748854 DOI: 10.4103/0366-6999.211541 |
0.302 |
|
| 2017 |
Li MH, Zhang L, Qu XJ, Lu Y, Shen G, Wu SL, Chang M, Liu RY, Hu LP, Li ZZ, Hua WH, Song SJ, Xie Y. Kinetics of Hepatitis B Surface Antigen Level in Chronic Hepatitis B Patients who Achieved Hepatitis B Surface Antigen Loss during Pegylated Interferon Alpha-2a Treatment. Chinese Medical Journal. 130: 559-565. PMID 28229987 DOI: 10.4103/0366-6999.200554 |
0.37 |
|
| 2015 |
Li MH, Hu LP, Zhang L, Lu Y, Shen G, Wu SL, Chang M, Mu CQ, Wu YZ, Yang M, Song SJ, Zhang SF, Hua WH, Xie Y, Cheng J, et al. [Efficacy of pegylated-interferon alpha-2a treatment in patients with HBeAg-positive chronic hepatitis B and partial viral response to nucleoside analogue therapy]. Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology. 23: 826-31. PMID 26743242 DOI: 10.3760/cma.j.issn.1007-3418.2015.11.006 |
0.367 |
|
| 2013 |
Zhao JM, Zhang L, Du QW, Mu CQ, Ren YL, Hu LP, Shen G, Zhuang LW, Lu Y, Qiu GH, Sun QF, Wu YZ, Yang M, Li MH, Xie Y, et al. [Analyse related factors of impact and prognosis of 73 cases of severe hepatitis]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi = Zhonghua Shiyan He Linchuang Bingduxue Zazhi = Chinese Journal of Experimental and Clinical Virology. 27: 366-9. PMID 24645325 |
0.345 |
|
| 2012 |
Li MH, Zhang YL, Zhang L, Shen G, Qiu GH, Lu Y, Zhuang LW, Gao YJ, Yang M, Wu Y, Xie Y, Cheng J, Xu D. [Study on effect of intensive treatment for refractory chronic hepatitis C patients]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi = Zhonghua Shiyan He Linchuang Bingduxue Zazhi = Chinese Journal of Experimental and Clinical Virology. 26: 374-8. PMID 23550318 |
0.371 |
|
| 2011 |
Lu Y, Zhang YL, Shen G, Zhang L, Wang L, Qiu GH, Wu YZ, Yang M, Li MH. [Clinical study on viral hepatitis combined with aplastic anemia]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi = Zhonghua Shiyan He Linchuang Bingduxue Zazhi = Chinese Journal of Experimental and Clinical Virology. 25: 283-5. PMID 22097608 |
0.341 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2018 |
Li MH, Zhang L, Zhang D, Cao WH, Qi TL, Hao HX, Wang XY, Ran CP, Qu XJ, Liu SA, Lu Y, Shen G, Wu SL, Chang M, Liu RY, et al. Plasmacytoid Dendritic Cell Function and Cytokine Network Profiles in Patients with Acute or Chronic Hepatitis B Virus Infection. Chinese Medical Journal. 131: 43-49. PMID 29271379 DOI: 10.4103/0366-6999.221275 |
0.298 |
|
| 2012 |
Zhang L, Shen G, Zhang YL, Qiu GH, Lu Y, Zhao H, Yang M, Li MH, Xie Y, Cheng J, Xu DZ. [Study on retreatment of CHC patients with initial treatment failure]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi = Zhonghua Shiyan He Linchuang Bingduxue Zazhi = Chinese Journal of Experimental and Clinical Virology. 26: 304-6. PMID 23189852 |
0.286 |
|
| 2023 |
Liu R, Yang L, Jiang T, Lu Y, Zhang L, Shen G, Wu S, Chang M, Hao H, Hu L, Gao Y, Xu M, Chen X, Yi W, Li M, et al. Hepatitis B core-related antigen serum levels may be a predictor of acute flare of chronic hepatitis B among pregnant women in the immune-tolerant phase of chronic HBV infection after short-course antiviral therapy. Virulence. 14: 2186335. PMID 36864005 DOI: 10.1080/21505594.2023.2186335 |
0.283 |
|
| 2016 |
Li MH, Xie Y, Zhang L, Lu Y, Shen G, Wu SL, Chang M, Mu CQ, Hu LP, Hua WH, Song SJ, Zhang SF, Cheng J, Xu DZ. Hepatitis B surface antigen clearance in inactive hepatitis B surface antigen carriers treated with peginterferon alfa-2a. World Journal of Hepatology. 8: 637-43. PMID 27239256 DOI: 10.4254/wjh.v8.i15.637 |
0.279 |
|
| 2013 |
Shen G, Zhang L, Zhang YL, Hu LP, Li MH, Lu Y, Li XH, Qiu GH, Zhuang LW, Mu CQ, Zhao H, Chen LJ, Yang M, Wu YZ, Xie Y, et al. [Study on the etiology of acute hepatitis hospitalized patients in Beijing Ditan Hospital from 2002 to 2011]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi = Zhonghua Shiyan He Linchuang Bingduxue Zazhi = Chinese Journal of Experimental and Clinical Virology. 27: 266-9. PMID 24579471 |
0.272 |
|
| 2022 |
Liu R, Li M, Lu Y, Zhang L, Shen G, Wu S, Chang M, Hao H, Hu L, Gao Y, Xu M, Xie Y. Hepatitis B core-related antigen serum levels are associated with significant liver fibrosis in treatment-naïve chronic HBV infection patients. Journal of Viral Hepatitis. PMID 35357759 DOI: 10.1111/jvh.13674 |
0.26 |
|
| 2018 |
Cao WH, Li MH, Pan CQ, Lu Y, Zhang L, Ran CP, Wu SL, Hua WH, Liu SA, Shen G, Chang M, Liu RY, Hao HX, Hu LP, Xie Y. Quantitation of Plasmacytoid Dendritic Cells in Chronic Hepatitis B Patients with HBeAg Positivity During PEG-IFN and Entecavir Therapy. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. 38: 197-205. PMID 29791282 DOI: 10.1089/jir.2018.0014 |
0.25 |
|
| 2023 |
Lin Y, Shen G, Xie S, Bi X, Lu H, Yang L, Jiang T, Deng W, Wang S, Zhang L, Lu Y, Gao Y, Hao H, Wu S, Liu R, et al. Dynamic changes of the proportion of HLA-DR and CD38 coexpression subsets on T lymphocytes during IFN-based chronic hepatitis B treatment. Frontiers in Immunology. 13: 1116160. PMID 36761161 DOI: 10.3389/fimmu.2022.1116160 |
0.241 |
|
| 2023 |
Zhang L, Jiang T, Yang Y, Deng W, Lu H, Wang S, Liu R, Chang M, Wu S, Gao Y, Hao H, Shen G, Xu M, Chen X, Hu L, et al. Postpartum hepatitis and host immunity in pregnant women with chronic HBV infection. Frontiers in Immunology. 13: 1112234. PMID 36685527 DOI: 10.3389/fimmu.2022.1112234 |
0.208 |
|
| 2022 |
Da Y, Shen G, Zhou M, Wang T, Dong D, Bu L, Shao Y, Sun Q, Yu R. Rapid subcutaneous progression after immunotherapy in pretreated patients with metastatic carcinoma: two case reports. The Journal of International Medical Research. 50: 3000605221094274. PMID 35469479 DOI: 10.1177/03000605221094274 |
0.197 |
|
| 2021 |
Zhang G, Lin L, Dong D, Qiu H, Liu T, Lian L, Shen G. Nivolumab plus regorafenib in patients with small bowel adenocarcinoma: A case report. Medicine. 100: e24295. PMID 33530218 DOI: 10.1097/MD.0000000000024295 |
0.183 |
|
| 2022 |
Yang G, Fang Y, Zhou M, Li W, Dong D, Chen J, Da Y, Wang K, Li X, Zhang X, Ma T, Shen G. Case report: The effective response to pembrolizumab in combination with bevacizumab in the treatment of a recurrent glioblastoma with multiple extracranial metastases. Frontiers in Oncology. 12: 948933. PMID 36052225 DOI: 10.3389/fonc.2022.948933 |
0.173 |
|
| 2020 |
Dong D, Shen G, Da Y, Zhou M, Yang G, Yuan M, Chen R. Successful Treatment of Patients with Refractory High-Grade Serous Ovarian Cancer with GOPC-ROS1 Fusion Using Crizotinib: A Case Report. The Oncologist. PMID 32652753 DOI: 10.1634/theoncologist.2019-0609 |
0.164 |
|
| 2012 |
Wang T, Zhang S, Zeng M, Lu X, Shen G, Wu S, Song S, Jiang Z. Gemcitabine and cisplatin combination regimen in patients with anthracycline- and taxane-pretreated metastatic breast cancer. Medical Oncology (Northwood, London, England). 29: 56-61. PMID 21264537 DOI: 10.1007/s12032-010-9814-7 |
0.158 |
|
| 2005 |
Shen G, Song ST, Jiang ZF, Bian SG, Xie GR, Wang YJ, Wang JJ. [Clinical study of zoledronic acid in the treatment of cancer-induced hypercalcemia]. Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]. 27: 632-4. PMID 16438878 |
0.137 |
|
| 2022 |
Xu K, Chen Z, Hou J, Dong C, Shi C, Gao L, Huang Z, Shen G, Wang T, Zhou Y. Praeruptorin B inhibits osteoclastogenesis by targeting GSTP1 and impacting on the S-glutathionylation of IKKβ. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 154: 113529. PMID 36030586 DOI: 10.1016/j.biopha.2022.113529 |
0.136 |
|
| 2016 |
Huang Z, Sun B, Shen G, Cha L, Meng X, Wang J, Zhou Z, Wu S. Brain metastasis reirradiation in patients with advanced breast cancer. Journal of Radiation Research. PMID 27707842 DOI: 10.1093/jrr/rrw087 |
0.134 |
|
| 2014 |
Shen G, Wang YJ, Shen WJ, Zhou ZS, Wang JL, Sheng HG, Dong DP, Zhou M, Yang G, Wang QW, Zeng Y. Stereotactic body radiation therapy for centrally-located lung tumors. Oncology Letters. 7: 1292-1296. PMID 24944711 DOI: 10.3892/ol.2014.1815 |
0.131 |
|
| 2017 |
Meng X, Zhao R, Shen G, Dong D, Ding L, Wu S. Efficacy and safety of bevacizumab treatment for refractory brain edema: Case report. Medicine. 96: e8280. PMID 29095257 DOI: 10.1097/MD.0000000000008280 |
0.125 |
|
| 2017 |
Liu C, Wu S, Meng X, Liu G, Chen D, Cong Y, Shen G, Sun B, Wang W, Wang Q, Gao H, Liu X. Predictive value of peripheral regulatory T cells in non-small cell lung cancer patients undergoing radiotherapy. Oncotarget. PMID 28624781 DOI: 10.18632/Oncotarget.15238 |
0.122 |
|
| 2020 |
Shen G, Wang W, Da Y, Li D, Bai L, Tai J, Liu G. Immunomodulatory features of radiotherapy in lung carcinoma. Translational Cancer Research. 9: 42-48. PMID 35117156 DOI: 10.21037/tcr.2019.11.07 |
0.119 |
|
| 2019 |
Cong Y, Sun B, Wang J, Meng X, Xuan L, Zhang J, Liu J, Shen G, Wu S. Outcomes and toxicity of stereotactic body radiation therapy for advanced stage ultra-central non-small cell lung cancer. Thoracic Cancer. PMID 31187604 DOI: 10.1111/1759-7714.13105 |
0.118 |
|
| 2021 |
Li P, Shen G, Zhu Z, Shi S, Hu Y, Zeng Z, Zhou H, Li Q, Zhu P, Yang G, Liu Z, Fu H, Hu J, He Y, Yang Q, et al. Dynamic changes of IgM and IgG antibodies in asymptomatic patients as an effective way to detect SARS-CoV-2 infection. Journal of Clinical Laboratory Analysis. e24080. PMID 34914135 DOI: 10.1002/jcla.24080 |
0.11 |
|
| 2004 |
Wang T, Jiang ZF, Song ST, Zhang SH, Shen G, Yu JX. [Single-agent Xeloda in the treatment of recurrent and metastatic breast cancer]. Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]. 26: 379-81. PMID 15312353 |
0.108 |
|
| 2020 |
Shi S, Su M, Shen G, Hu Y, Yi F, Zeng Z, Zhu P, Yang G, Zhou H, Li Q, Xie X. Matrix Metalloproteinase 3 as a Valuable Marker for Patients with COVID-19. Journal of Medical Virology. PMID 32603484 DOI: 10.1002/jmv.26235 |
0.107 |
|
| 2017 |
Meng X, Zhao R, Shikai W, Shen G, Ding L, Sun B, Wang J. Efficacy of repeated low-dose bevacizumab treatment with long-dosing interval for radiation-induced brain necrosis: a case report. Cancer Biology & Therapy. 0. PMID 28152324 DOI: 10.1080/15384047.2016.1276127 |
0.106 |
|
| 2018 |
Huang Z, Sun B, Wu S, Meng X, Cong Y, Shen G, Song S. A nomogram for predicting survival in patients with breast cancer brain metastasis. Oncology Letters. 15: 7090-7096. PMID 29725432 DOI: 10.3892/ol.2018.8259 |
0.104 |
|
| 2015 |
Shen G, Wang YJ, Guan YJ, Dong DP, Yang G, Li D, Hao RM, Sun HR, Zhou M, Wang KP, Zhou SX, Wang QW, Wu SK, Zeng YJ. Relief Effect of Bevacizumab on Severe Edema Induced by Re-irradiation in Brain Tumor Patients. Chinese Medical Journal. 128: 2126-2129. PMID 26228232 DOI: 10.4103/0366-6999.161403 |
0.098 |
|
| 2015 |
Sun B, Huang Z, Wu S, Shen G, Cha L, Meng X, Ding L, Wang J, Song S. Incidence and relapse risk of intracranial metastases within the perihippocampal region in 314 patients with breast cancer. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 26674923 DOI: 10.1016/j.radonc.2015.11.010 |
0.09 |
|
| 2016 |
Sun B, Huang Z, Wu S, Ding L, Shen G, Cha L, Wang J, Song S. Cystic brain metastasis is associated with poor prognosis in patients with advanced breast cancer. Oncotarget. PMID 27659537 DOI: 10.18632/oncotarget.12176 |
0.087 |
|
| 2005 |
Liu F, Jiang ZF, Song ST, Liu XQ, Wang T, Yan M, Zhang SH, Hao CF, Sun JZ, Shen G. [Relation of dose intensity and efficacy, toxicity in paclitaxel as a single agent for advanced breast cancer]. Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]. 27: 56-8. PMID 15771802 |
0.078 |
|
| 2019 |
Cong Y, Xuan L, Sun B, Wang J, Meng X, Zhang J, Xue J, Liu J, Shen G, Wu S. Retrospective comparison of stereotactic body radiotherapy versus intensity-modulated radiotherapy for stage III ultra-central squamous non-small-cell lung cancer. Future Oncology (London, England). PMID 30950297 DOI: 10.2217/fon-2019-0061 |
0.074 |
|
| 2016 |
Cong Y, Shen G, Wu S, Hao R. Abscopal Regression Following SABR for Non-Small-Cell-Lung Cancer: a Case Report. Cancer Biology & Therapy. 0. PMID 27922336 DOI: 10.1080/15384047.2016.1264541 |
0.072 |
|
| 2009 |
Liu S, Weng W, Li Z, Pan L, Cheng K, Song C, Du P, Shen G, Han G. Effect of PEG amount in amorphous calcium phosphate on its crystallized products. Journal of Materials Science. Materials in Medicine. 20: 359-63. PMID 18807264 DOI: 10.1007/s10856-008-3584-1 |
0.071 |
|
| 2014 |
Deng S, Xu G, Bai H, Li L, Jiang S, Shen G, Han G. Hydrothermal synthesis of single-crystalline perovskite PbTiO3 nanosheets with dominant (001) facets. Inorganic Chemistry. 53: 10937-43. PMID 25264615 DOI: 10.1021/ic501180g |
0.065 |
|
| 2007 |
Jiang Zf, Shen G. The requirements to clinicopathology about targeted therapy for breast cancer Zhonghua Bing Li Xue Za Zhi Chinese Journal of Pathology. 36: 435-437. PMID 17845752 |
0.06 |
|
| 2017 |
Wang W, Shen G, Wu S, Song S, Ni Y, Suo Z, Meng X, Li D, Zhou L, Hao R, Zhao Y, Bai L, Hou L, Liu B, Liu G. PD-1 mRNA expression in peripheral blood cells and its modulation characteristics in cancer patients. Oncotarget. 8: 50782-50791. PMID 28881603 DOI: 10.18632/Oncotarget.15006 |
0.059 |
|
| 2016 |
Chen F, Ren Z, Gong S, Li X, Shen G, Han G. Selective Deposition of Silver Oxide on Single-Domain Ferroelectric Nanoplates and Their Efficient Visible-Light Photoactivity. Chemistry (Weinheim An Der Bergstrasse, Germany). PMID 27430192 DOI: 10.1002/chem.201601456 |
0.052 |
|
| 2009 |
Luo M, Cheng K, Weng W, Song C, Du P, Shen G, Xu G, Han G. Enhanced Luminescence of Eu-Doped TiO2Nanodots. Nanoscale Research Letters. 4: 809-13. PMID 20596343 DOI: 10.1007/s11671-009-9319-5 |
0.046 |
|
| 2009 |
Luo M, Cheng K, Weng W, Song C, Du P, Shen G, Xu G, Han G. Size- and density-controlled synthesis of TiO2 nanodots on a substrate by phase-separation-induced self-assembly. Nanotechnology. 20: 215605. PMID 19423936 DOI: 10.1088/0957-4484/20/21/215605 |
0.042 |
|
| 2012 |
Shen G, Wang YJ, Sheng HG, Duan XP, Wang JL, Zhang WJ, Zhou ZS, Zhu GY, Xia TY. Double CT imaging can measure the respiratory movement of small pulmonary tumors during stereotactic ablative radiotherapy. Journal of Thoracic Disease. 4: 131-40. PMID 22833818 DOI: 10.3978/j.issn.2072-1439.2012.01.04 |
0.04 |
|
| 2008 |
Sun H, Luo M, Weng W, Cheng K, Du P, Shen G, Han G. Position and density control in hydrothermal growth of ZnO nanorod arrays through pre-formed micro/nanodots. Nanotechnology. 19: 395602. PMID 21832598 DOI: 10.1088/0957-4484/19/39/395602 |
0.039 |
|
| 2011 |
Li Q, Cheng K, Weng W, Song C, Du P, Shen G, Han G. Room-temperature nonequilibrium growth of controllable ZnO nanorod arrays. Nanoscale Research Letters. 6: 477. PMID 21794165 DOI: 10.1186/1556-276X-6-477 |
0.038 |
|
| 2023 |
Hu Z, Wu T, Zhou Z, Zhang Y, Chen Q, Yao H, Ji M, Shen G, Dong C, Shi C, Huang Z, Jiang N, Han N, Tian X. Asiaticoside Attenuates Blood-Spinal Cord Barrier Disruption by Inhibiting Endoplasmic Reticulum Stress in Pericytes After Spinal Cord Injury. Molecular Neurobiology. PMID 37653222 DOI: 10.1007/s12035-023-03605-3 |
0.036 |
|
| 2014 |
Jiang S, Ren Z, Yin S, Gong S, Yu Y, Li X, Wei X, Xu G, Shen G, Han G. Growth and bending-sensitive photoluminescence of a flexible PbTiO₃/ZnO nanocomposite. Acs Applied Materials & Interfaces. 6: 10935-40. PMID 24984158 DOI: 10.1021/am5009024 |
0.036 |
|
| 2012 |
Chen Z, Li X, He H, Ren Z, Liu Y, Wang J, Li Z, Shen G, Han G. Mesoporous silica nanoparticles with manipulated microstructures for drug delivery. Colloids and Surfaces. B, Biointerfaces. 95: 274-8. PMID 22494670 DOI: 10.1016/j.colsurfb.2012.03.012 |
0.035 |
|
| 2008 |
Sun H, Luo M, Weng W, Cheng K, Du P, Shen G, Han G. Room-temperature preparation of ZnO nanosheets grown on Si substrates by a seed-layer assisted solution route. Nanotechnology. 19: 125603. PMID 21817735 DOI: 10.1088/0957-4484/19/12/125603 |
0.033 |
|
| 2004 |
Shen GZ, Wang XQ, Yin LQ, Wang HM. [Determination of amylose content in transgenic progenies containing an antisense waxy gene and identifying of pure lines in indica rice]. Shi Yan Sheng Wu Xue Bao. 37: 429-36. PMID 15789760 |
0.033 |
|
| 2008 |
Zou C, Weng W, Cheng K, Du P, Shen G, Han G. Preparation of nanosized beta-tricalcium phosphate particles with Zn substitution. Journal of Materials Science. Materials in Medicine. 19: 1133-6. PMID 17701318 DOI: 10.1007/s10856-007-0170-x |
0.033 |
|
| 2021 |
Lu Q, Zhu Z, Tan C, Zhou H, Hu Y, Shen G, Zhu P, Yang G, Xie X. Changes of serum IL-10, IL-1β, IL-6, MCP-1, TNF-α, IP-10 and IL-4 in COVID-19 patients. International Journal of Clinical Practice. e14462. PMID 34107113 DOI: 10.1111/ijcp.14462 |
0.033 |
|
| 2002 |
Shen GZ, Wang XQ, Wang J, Wan XS, Li L, Zhang JL. [The morphology observation, mechanics intensity test and genetic analysis of brittle culm mutant bcm581-1 in rice]. Shi Yan Sheng Wu Xue Bao. 35: 307-12. PMID 15346989 |
0.032 |
|
| 2019 |
Shu Y, Guo P, Li X, Li G, Wang P, Shen G, Li J. Gold Nanorods as Saturable Absorber for Harmonic Soliton Molecules Generation. Frontiers in Chemistry. 7: 715. PMID 31709238 DOI: 10.3389/fchem.2019.00715 |
0.031 |
|
| 2005 |
Zou C, Weng W, Deng X, Cheng K, Liu X, Du P, Shen G, Han G. Preparation and characterization of porous beta-tricalcium phosphate/collagen composites with an integrated structure. Biomaterials. 26: 5276-84. PMID 15814125 DOI: 10.1016/j.biomaterials.2005.01.064 |
0.031 |
|
| 2014 |
Yin S, Tian H, Ren Z, Wei X, Chao C, Pei J, Li X, Xu G, Shen G, Han G. Octahedral-shaped perovskite nanocrystals and their visible-light photocatalytic activity. Chemical Communications (Cambridge, England). 50: 6027-30. PMID 24769605 DOI: 10.1039/c4cc01118j |
0.029 |
|
| 2019 |
Guo N, Shen G, Zhang Y, Moustafa AA, Ge D, You Z. Interleukin-17 Promotes Migration and Invasion of Human Cancer Cells Through Upregulation of MTA1 Expression. Frontiers in Oncology. 9: 546. PMID 31281798 DOI: 10.3389/fonc.2019.00546 |
0.028 |
|
| 2006 |
Gao Y, Weng W, Cheng K, Du P, Shen G, Han G, Guan B, Yan W. Preparation, characterization and cytocompatibility of porous ACP/PLLA composites. Journal of Biomedical Materials Research. Part A. 79: 193-200. PMID 16826600 DOI: 10.1002/jbm.a.30761 |
0.026 |
|
| 2018 |
Liu H, Wu WB, Shen G, Huang Q. Spatio-temporal evolution of traditional soybean planting structure in Songnen Plain, China in 1996-2016. Ying Yong Sheng Tai Xue Bao = the Journal of Applied Ecology. 29: 3275-3282. PMID 30325152 DOI: 10.13287/j.1001-9332.201810.011 |
0.022 |
|
| 2004 |
Cheng K, Weng W, Qu H, Du P, Shen G, Han G, Yang J, Ferreira JM. Sol-gel preparation and in vitro test of fluorapatite/hydroxyapatite films. Journal of Biomedical Materials Research. Part B, Applied Biomaterials. 69: 33-7. PMID 15015207 DOI: 10.1002/jbm.b.20027 |
0.021 |
|
| 2007 |
Miao S, Weng W, Cheng K, Du P, Shen G, Han G, Huang X, Yan W, Zhang S. In vitro bioactivity and osteoblast-like cell test of zinc containing fluoridated hydroxyapatite films. Journal of Materials Science. Materials in Medicine. 18: 2101-5. PMID 17562136 DOI: 10.1007/s10856-007-3131-5 |
0.021 |
|
| 2003 |
Shen GZ, Wang XQ, Yin LQ, Wang J, Li L, Zhang JL. [Genetic analysis of a rolled-leaf mutant in rice population of T-DNA insertion]. Shi Yan Sheng Wu Xue Bao. 36: 459-64. PMID 14724937 |
0.021 |
|
| 2009 |
Miao S, Weng W, Li Z, Cheng K, Du P, Shen G, Han G. Electrolytic deposition of octacalcium phosphate/collagen composite coating on titanium alloy. Journal of Materials Science. Materials in Medicine. 20: 131-4. PMID 18704651 DOI: 10.1007/s10856-008-3552-9 |
0.02 |
|
| 2010 |
Ren Z, Xu G, Liu Y, Wei X, Zhu Y, Zhang X, Lv G, Wang Y, Zeng Y, Du P, Weng W, Shen G, Jiang JZ, Han G. PbTiO3 nanofibers with edge-shared TiO6 octahedra. Journal of the American Chemical Society. 132: 5572-3. PMID 20364814 DOI: 10.1021/ja1011614 |
0.02 |
|
| 2012 |
Liu Z, Ren Z, Xiao Z, Chao C, Wei X, Liu Y, Li X, Xu G, Shen G, Han G. Size-controlled single-crystal perovskite PbTiO3 nanofibers from edge-shared TiO6 octahedron columns. Small (Weinheim An Der Bergstrasse, Germany). 8: 2959-63. PMID 22821902 DOI: 10.1002/smll.201200795 |
0.018 |
|
| 2008 |
Miao S, Cheng K, Weng W, Du P, Shen G, Han G, Yan W, Zhang S. Fabrication and evaluation of Zn containing fluoridated hydroxyapatite layer with Zn release ability. Acta Biomaterialia. 4: 441-6. PMID 17942380 DOI: 10.1016/j.actbio.2007.08.013 |
0.018 |
|
| 2012 |
Chao C, Ren Z, Zhu Y, Xiao Z, Liu Z, Xu G, Mai J, Li X, Shen G, Han G. Self-templated synthesis of single-crystal and single-domain ferroelectric nanoplates. Angewandte Chemie (International Ed. in English). 51: 9283-7. PMID 22893500 DOI: 10.1002/anie.201204792 |
0.014 |
|
| 2003 |
Fang L, Weng W, Shen G, Han G, Santos JD, Du P. [Bone tissue engineering scaffolds]. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi = Journal of Biomedical Engineering = Shengwu Yixue Gongchengxue Zazhi. 20: 148-52. PMID 12744187 |
0.013 |
|
| 2008 |
Zou C, Weng W, Cheng K, Du P, Shen G, Han G, Guan B, Yan W. Porous beta-tricalcium phosphate/collagen composites prepared in an alkaline condition. Journal of Biomedical Materials Research. Part A. 87: 38-44. PMID 18080301 DOI: 10.1002/jbm.a.31686 |
0.011 |
|
| Hide low-probability matches. |